A designed chimeric virus induced broadly neutralizing antibodies (bNAbs) against the macaque equivalent of HIV. The strategy ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University ...

Study results indicate suboptimal adherence to HIV-specific immunization recommendations among pediatric patients receiving ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University ...

Amid ongoing efforts to combat HIV, South Africa initiates the BRILLIANT 011 trial, staking a claim in the search for an effective vaccine. Despite the challenges ahead, this trial ignites a beacon of ...

Fauci says anti-vax culture kept the US from reaching 72% vaccination, but highly vaccinated countries still saw record COVID ...

The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles ...

"You cannot end an epidemic while drawing lines around who deserves treatment, because the virus does not recognise the lines ...

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Researchers from Karolinska Institutet, with partners from The Scripps Research Institute and Emory University, have developed an experimental HIV vaccine that trained animal immune systems to produce ...